株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マルチモーダルイメージングの世界市場 - 2024年までの予測:PET/CT、SPECT/CT、PET/MR、OCT/眼底イメージングシステム

Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 911270
出版日 ページ情報 英文 142 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
マルチモーダルイメージングの世界市場 - 2024年までの予測:PET/CT、SPECT/CT、PET/MR、OCT/眼底イメージングシステム Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecast to 2024
出版日: 2019年09月13日 ページ情報: 英文 142 Pages
概要

世界のマルチモーダルイメージング市場は、2019年の23億米ドルから、2024年までに29億米ドルまで拡大すると見られています。市場は、2019年~2024年のCAGR (複合年間成長率) で、4.4%の成長が予測されています。

当レポートでは、世界のマルチモーダルイメージング市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

911270_4.1 MULTIMODAL IMAGING MARKET OVERVIEW_FIGURE 11

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • マルチモーダルイメージング:市場概要
  • 地域分析 - マルチモーダルイメージング市場シェア:用途別、地域別
  • 技術分析 - マルチモーダルイメージング市場規模
  • エンドユーザー分析 - マルチモーダルイメージング市場シェア
  • マルチモーダルイメージング市場の地域別スナップショット

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 マルチモーダルイメージングの世界市場:技術別

  • イントロダクション
  • PET/CTシステム
  • SPECT/CTシステム
  • PET/MRシステム
  • OCT/眼底イメージングシステム
  • その他

第7章 マルチモーダルイメージングの世界市場:用途別

  • イントロダクション
  • 腫瘍
  • 眼科
  • 心臓
  • 脳・神経
  • その他

第8章 マルチモーダルイメージングの世界市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 画像診断センター
  • その他

第9章 マルチモーダルイメージングの世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • イントロダクション
  • 市場シェア分析
  • 競合状況・動向
  • 競合リーダーシップマッピング
  • ベンダー選定基準
  • ベンダー分析

第11章 企業プロファイル

  • キヤノン
  • GE HEALTHCARE
  • HEIDELBERG ENGINEERING
  • INFRAREDX, INC. (ニプロの一部)
  • KONINKLIJKE PHILIPS N.V.
  • MEDISO MEDICAL IMAGING SYSTEMS KFT
  • NEUSOFT MEDICAL SYSTEMS CO., LTD
  • SIEMENS HEALTHINEERS
  • SPECTRUM DYNAMICS MEDICAL
  • トプコン
  • UNITED IMAGING HEALTHCARE CO., LTD.
  • ZEISS GROUP

第12章 付録

図表

LIST OF TABLES

  • TABLE 1: TECHNOLOGICAL ADVANCEMENTS IN MULTIMODAL IMAGING SYSTEMS (2017-2019)
  • TABLE 2: CODES FOR SPECT/CT FUSION IMAGING (AS OF JUNE 2019)
  • TABLE 3: NATIONAL PET, PET/CT, PET/MRI COVERAGE FOR ONCOLOGY (AS OF JUNE 2013)
  • TABLE 4: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 5: PET/CT SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: PET/CT SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 7: PET/CT SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 8: SPECT/CT SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: SPECT/CT SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 10: SPECT/CT SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 11: PET/MR SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: PET/MR SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 13: PET/MR SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 14: OCT/FUNDUS IMAGING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: OCT/FUNDUS IMAGING SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 16: OCT/FUNDUS IMAGING SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 17: OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 19: OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 20: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 21: MULTIMODAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: MULTIMODAL IMAGING MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: MULTIMODAL IMAGING MARKET FOR BRAIN AND NEUROLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: MULTIMODAL IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: MULTIMODAL IMAGING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 27: MULTIMODAL IMAGING SYSTEMS INSTALLED IN HOSPITALS
  • TABLE 28: MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: MULTIMODAL IMAGING SYSTEMS INSTALLED IN DIAGNOSTIC IMAGING CENTERS
  • TABLE 30: MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: MULTIMODAL IMAGING SYSTEMS INSTALLED IN RESEARCH AND ACADEMIC INSTITUTES
  • TABLE 32: MULTIMODAL IMAGING MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: MULTIMODAL IMAGING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 38: US: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 39: CANADA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 40: EUROPE: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41: EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 42: EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 43: EUROPE: MULTIMODAL IMAGING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 44: GERMANY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 45: UK: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 46: FRANCE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 47: REST OF EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 48: ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 49: ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 50: ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 51: ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 52: JAPAN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 53: CHINA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 54: INDIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 55: REST OF ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 56: LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 57: LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 58: LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 59: LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 60: BRAZIL: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 61: MEXICO: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 62: REST OF LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 63: MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 64: MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 65: MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 66: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
  • TABLE 67: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  • TABLE 68: EXPANSIONS
  • TABLE 69: ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: MULTIMODAL IMAGING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5: MARKET SIZE ESTIMATION: OVERALL MULTIMODAL IMAGING MARKET
  • FIGURE 6: MULTIMODAL IMAGING MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: MULTIMODAL IMAGING MARKET SHARE, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE MULTIMODAL IMAGING MARKET
  • FIGURE 11: TECHNOLOGICAL ADVANCEMENTS IN MULTIMODAL IMAGING AND DEMAND FOR EARLY DIAGNOSIS ARE DRIVING MARKET GROWTH
  • FIGURE 12: ONCOLOGY SEGMENT IS EXPECTED TO DOMINATE THE MARKET WITH THE LARGEST SHARE OF THE MULTIMODAL IMAGING MARKET
  • FIGURE 13: PET/CT SEGMENT IS EXPECTED TO HOLD THE DOMINANT MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 14: HOSPITALS SEGMENT IS EXPECTED TO HOLD A DOMINANT MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 15: CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: MULTIMODAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: NORTH AMERICA: MULTIMODAL IMAGING MARKET SNAPSHOT
  • FIGURE 18: EUROPE: MULTIMODAL IMAGING MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: MULTIMODAL IMAGING MARKET SNAPSHOT
  • FIGURE 20: KEY DEVELOPMENTS IN THE MULTIMODAL IMAGING MARKET BETWEEN 2016 AND 2019
  • FIGURE 21: GLOBAL MULTIMODAL IMAGING MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 22: MULTIMODAL IMAGING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 23: CANON, INC.: COMPANY SNAPSHOT
  • FIGURE 24: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 25: NIPRO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 26: KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 27: NEUSOFT: COMPANY SNAPSHOT
  • FIGURE 28: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 29: TOPCON CORPORATION: COMPANY SNAPSHOT
  • FIGURE 30: CARL ZEISS AG: COMPANY SNAPSHOT
目次
Product Code: MD 7353

"The global multimodal imaging market is projected to grow at a CAGR of 4.4% during the forecast period."

Multimodal imaging includes PET/CT systems, SPECT/CT systems, PET/MR systems, OCT/Fundus Imaging systems, and other multimodal imaging systems. The global multimodal imaging market is projected to reach USD 2.9 billion by 2024 from USD 2.3 billion in 2019, at a CAGR of 4.4% from 2019 to 2024.

Growing applications of multimodal imaging systems, technological advancements in diagnostic imaging modalities, availability of funding for research, favorable reimbursement scenario, growing insurance coverage, and increasing R&D into radiotracers are some of the key factors driving the multimodal imaging market. However, the high cost of multimodal imaging systems, lack of infrastructure in emerging countries, and a dearth of trained professionals are expected to limit market growth to a certain extent.

"The PET/CT systems segment accounted for the largest share of the global multimodal imaging market in 2018."

Based on technology, the multimodal imaging market is broadly segmented into PET/CT systems, PET/MR systems, SPECT/CT systems, OCT/Fundus Imaging systems, and other multimodal imaging systems (tri-modality systems such as SPECT/CT/PET, PET/CT + MR, and IVUS + NIRS systems, among others). The PET/CT systems segment accounted for the largest share of the multimodal imaging market in 2018. This can be attributed to the increasing demand for early and accurate cancer diagnosis, growing clinical evidence for the early detection of Alzheimer's disease, increasing applications of PET/CT systems in cardiology, favorable reimbursement scenario, and the technological advancements in the field of PET/CT.

"The oncology segment accounted for the largest share of the multimodal imaging market in 2018."

On the basis of application, the multimodal imaging market is segmented into brain & neurology, cardiology, oncology, ophthalmology, and other applications. The oncology segment accounted for the largest market share in 2018. This can be attributed to the expanding use of multimodal imaging systems in oncology diagnosis, increasing demand for the early & accurate diagnosis of cancer, and growing clinical evidence on the use of multimodal imaging in the diagnosis of novel cancer types.

"Europe accounted for the second-largest share of the global market in 2018."

The multimodal imaging market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share of the market in 2018. Factors such as growing product approvals and rising public-private investments for developing multimodal imaging modalities for novel applications are the major factors driving market growth in Europe.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (30%), Tier 2 (32%), and Tier 3 (38%)
  • By Designation: C-level (26%), Director-level (30%), and Others (44%)
  • By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

The major players operating in the multimodal imaging market are: GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), United Imaging Healthcare Co., Ltd. (China), Canon Medical Systems Corporation (Japan), Mediso Medical Imaging Kft (Hungary), Neusoft Medical Systems Co., Ltd. (China), Spectrum Dynamics Medical (Switzerland), Infraredx, Inc. (Japan), Topcon Corporation (Japan), Carl Zeiss AG (Germany), and Heidelberg Engineering (Germany).

Research Coverage:

This report studies the multimodal imaging market based on technology, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the multimodal imaging market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Table of Contents

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKETS SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
    • 2.4.1 ASSUMPTIONS FOR THE STUDY
    • 2.4.2 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 MULTIMODAL IMAGING: MARKET OVERVIEW
  • 4.2 GEOGRAPHIC ANALYSIS: MULTIMODAL IMAGING MARKET SHARE, BY APPLICATION AND REGION, 2018
  • 4.3 TECHNOLOGY ANALYSIS: MULTIMODAL IMAGING MARKET SIZE, 2019 VS 2024 (USD MILLION)
  • 4.4 END-USER ANALYSIS: MULTIMODAL IMAGING MARKET SHARE, 2019 VS 2024
  • 4.5 GEOGRAPHIC SNAPSHOT OF THE MULTIMODAL IMAGING MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing applications of multimodal imaging systems
      • 5.2.1.2 Technological advancements in diagnostic imaging modalities
      • 5.2.1.3 Availability of funding for research
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of multimodal imaging systems
      • 5.2.2.2 Lack of adequate healthcare infrastructure
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Availability of reimbursement and insurance coverage for scans
      • 5.2.3.2 Increasing R&D into radiotracers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of trained professionals

6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 PET/CT SYSTEMS
    • 6.2.1 PET/CT SYSTEMS HAVE ALMOST PRACTICALLY REPLACED STAND-

ALONE PET SYSTEMS ACROSS THE WORLD 45

    • 6.2.2 PET/CT SYSTEMS MARKET SPLIT BY APPLICATION, 2017-2024 (USD MILLION)
    • 6.2.3 PET/CT SYSTEMS MARKET SPLIT BY END USER, 2017-2024 (USD MILLION)
  • 6.3 SPECT/CT SYSTEMS
    • 6.3.1 IMPROVED RESOLUTION OF SPECT/CT SYSTEMS HAS PROVIDED A CLEAR ADVANTAGE OVER STAND-ALONE SPECT SYSTEMS
    • 6.3.2 SPECT/CT SYSTEMS MARKET SPLIT BY APPLICATION, 2017-2024 (USD MILLION)
    • 6.3.3 SPECT/CT SYSTEMS MARKET SPLIT BY END USER, 2017-2024 (USD MILLION)
  • 6.4 PET/MR SYSTEMS
    • 6.4.1 PET/MR SYSTEMS SHOWCASE INCREASING CLINICAL EVIDENCE WITH ENHANCED TISSUE CONTRAST
    • 6.4.2 PET/MR SYSTEMS MARKET SPLIT BY APPLICATION, 2017-2024 (USD MILLION)
    • 6.4.3 PET/MR SYSTEMS MARKET SPLIT BY END USER, 2017-2024 (USD MILLION)
  • 6.5 OCT/FUNDUS IMAGING SYSTEMS
    • 6.5.1 OCT/FUNDUS IMAGING SYSTEMS HAVE WIDE APPLICATIONS IN RETINAL DISEASE DIAGNOSIS
    • 6.5.2 OCT/FUNDUS IMAGING SYSTEMS MARKET SPLIT BY APPLICATION, 2017-2024 (USD MILLION)
    • 6.5.3 OCT/FUNDUS IMAGING SYSTEMS MARKET SPLIT BY END USER, 2017-2024 (USD MILLION)
  • 6.6 OTHER MULTIMODAL IMAGING SYSTEMS
    • 6.6.1 OTHER MULTIMODAL IMAGING SYSTEMS MARKET SPLIT BY APPLICATION, 2017-2024 (USD MILLION)
    • 6.6.2 OTHER MULTIMODAL IMAGING SYSTEMS MARKET SPLIT BY END USER, 2017-2024 (USD MILLION)

7 MULTIMODAL IMAGING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 ONCOLOGY
    • 7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT OF THE MULTIMODAL IMAGING MARKET
  • 7.3 OPHTHALMOLOGY
    • 7.3.1 TECHNOLOGICAL INNOVATIONS IN OPHTHALMIC MULTIMODAL IMAGING SYSTEMS BY KEY MARKET PLAYERS TO SUPPORT MARKET GROWTH
  • 7.4 CARDIOLOGY
    • 7.4.1 INCREASING PREVALENCE OF CARDIAC CONDITIONS & INCREASING DEMAND FOR EARLY DISEASE DIAGNOSIS TO SUPPORT MARKET GROWTH
  • 7.5 BRAIN & NEUROLOGY
    • 7.5.1 INCREASING INCIDENCE OF BRAIN & NEUROLOGICAL DISORDERS TO PROPEL THE ADOPTION OF MULTIMODAL IMAGING SYSTEMS
  • 7.6 OTHER APPLICATIONS

8 MULTIMODAL IMAGING MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 LARGE HOSPITALS WITH NUCLEAR MEDICINE DEPARTMENTS HAVE BEEN EARLY ADOPTERS OF MULTIMODAL IMAGING SYSTEMS
  • 8.3 DIAGNOSTIC IMAGING CENTERS
    • 8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS IS CONTRIBUTING TO THE GROWTH OF THIS SEGMENT
  • 8.4 OTHER END USERS

9 MULTIMODAL IMAGING MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American multimodal imaging market
    • 9.2.2 CANADA
      • 9.2.2.1 Government budget cuts and long wait time for scans to hamper the market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Favorable reimbursement scenario in the country to support market growth
    • 9.3.2 UK
      • 9.3.2.1 Government initiatives and the increasing number of funding and research activities related to the use of multimodal imaging are driving market growth
    • 9.3.3 FRANCE
      • 9.3.3.1 France has the third-largest government expenditure on healthcare-a major factor driving market growth
    • 9.3.4 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Large installation base of hybrid imaging systems - a major factor driving market growth
    • 9.4.2 CHINA
      • 9.4.2.1 China to witness the highest growth rate in the global multimodal imaging market during the forecast period
    • 9.4.3 INDIA
      • 9.4.3.1 Lack of reimbursement for diagnostic imaging procedures to hamper market growth
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 BRAZIL
      • 9.5.1.1 Brazil dominates the Latin American multimodal imaging market due to the high burden of cancer
    • 9.5.2 MEXICO
      • 9.5.2.1 Rising incidence of cancer to drive market growth in Mexico
    • 9.5.3 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 IMPROVED HEALTHCARE INFRASTRUCTURE AND GROWING AWARENESS OF MULTIMODAL IMAGING ARE DRIVING MARKET GROWTH IN THE MEA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2018
  • 10.3 COMPETITIVE SITUATION AND TRENDS
  • 10.4 COMPETITIVE LEADERSHIP MAPPING
  • 10.5 VENDOR INCLUSION CRITERIA
  • 10.6 VENDOR DIVE
    • 10.6.1 VISIONARY LEADERS
    • 10.6.2 INNOVATORS
    • 10.6.3 DYNAMIC DIFFERENTIATORS
    • 10.6.4 EMERGING PLAYERS

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 CANON, INC.
  • 11.2 GE HEALTHCARE
  • 11.3 HEIDELBERG ENGINEERING
  • 11.4 INFRAREDX, INC. (A PART OF NIPRO CORPORATION)
  • 11.5 KONINKLIJKE PHILIPS N.V.
  • 11.6 MEDISO MEDICAL IMAGING SYSTEMS KFT
  • 11.7 NEUSOFT MEDICAL SYSTEMS CO., LTD
  • 11.8 SIEMENS HEALTHINEERS
  • 11.9 SPECTRUM DYNAMICS MEDICAL
  • 11.10 TOPCON CORPORATION
  • 11.11 UNITED IMAGING HEALTHCARE CO., LTD.
  • 11.12 ZEISS GROUP

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Back to Top